Safeguard Scientifics, Inc. (NYSE:SFE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.>
Safeguard Scientifics, Inc. (NYSE:SFE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
In April 2016, Dechra Pharmaceuticals Plc. acquired Putney, Inc. (“Putney”), which at the time was a partner company of Safeguard Scientifics, Inc. (the “Company”). The acquisition of Putney resulted in the Company receiving initial cash proceeds of $58.2 million. In connection with such acquisition, on January 25, 2017 the Compensation Committee of the Company’s Board of Directors approved the payment of a special cash bonus to Stephen T. Zarrilli, the Company’s Chief Executive Officer, in the amount of $175,000 in recognition of Mr. Zarrilli’s work and efforts on behalf of the Company relating to Putney over the course of the Company’s ownership of its interests in Putney. The payment of the foregoing bonus is contingent upon completion of the Company’s annual audit for the 2016 fiscal year.
About Safeguard Scientifics, Inc. (NYSE:SFE)
Safeguard Scientifics, Inc. provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech). The Technology segment’s companies focuses principally on digital media, financial technology (FinTech), and enterprise software, including mobile technology, cloud, Internet of Things (IoT) and big data. It holds interests in approximately 30 non-consolidated partner companies, which are included in the Healthcare and Technology segments. The Company provides management and operational support, as well as ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management. Safeguard Scientifics, Inc. (NYSE:SFE) Recent Trading Information
Safeguard Scientifics, Inc. (NYSE:SFE) closed its last trading session down -0.05 at 12.00 with 44,351 shares trading hands.
Safeguard Scientifics, Inc. provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech). The Technology segment’s companies focuses principally on digital media, financial technology (FinTech), and enterprise software, including mobile technology, cloud, Internet of Things (IoT) and big data. It holds interests in approximately 30 non-consolidated partner companies, which are included in the Healthcare and Technology segments. The Company provides management and operational support, as well as ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management. Safeguard Scientifics, Inc. (NYSE:SFE) Recent Trading Information
Safeguard Scientifics, Inc. (NYSE:SFE) closed its last trading session down -0.05 at 12.00 with 44,351 shares trading hands.
